Abstract:AIM: β-Arrestin-1 is an adaptor protein essential in G-protein-coupled receptor signaling and function. Recently, a mechanism by which β-arrestin-1 acted as a scaffolding molecule that regulated signaling pathways of receptor tyrosine kinases was discovered. The goal of this study is to determine the roles of β-arrestin-1 in RON-activated MAP kinase signaling that regulates tumorigenic activities of colon cancer cells. METHODS: Immunohistochemistry of tumor tissue arrays was used to determine RON and β-arrestin-1 expression. Immunoprecipitation and Western blotting were used to determine protein interaction and phosphorylation. Specific siRNA was used to silence β-arrestin-1 gene expression. Cell growth, transformation, and migration were determined by proliferation, focus formation and migration assays. RESULTS: Overexpression of RON (52/88 cases, 59.1%) in primary colon cancer samples was significantly matched with β-arrestin-1 expression. In 52 samples with RON overexpression, β-arrestin-1 was co-expressed in 41 cases (46.6%). In colon cancer HT-29 and other cells, β-arrestin-1 formed a signaling protein complex with RON and c-Src. RON-mediated dephosphorylation of β-arrestin-1 at Ser-412 increased their interaction. Silencing of β-arrestin-1 gene expression by siRNA techniques impaired RON-mediated Erk1/2 phosphorylation but had no effect on AKT phosphorylation. The β-arrestin-1 gene disruption also blocked oncogenic RON160- mediated cellular transformation in rodent fibroblast and colonic epithelial cells. Moreover, silencing β-arrestin-1 gene expression significantly reduced RON agonistic mAb Zt/c1-induced colon cancer cell proliferation but not migration. CONCLUSION: β-Arrestin-1 was selectively involved in RON-transduced signals. The requirement of β-arrestin-1 in MAP kinase signaling shed light on the mechanisms by which RON regulated malignancy of colon cancer cells. © 2010 MedUnion Press - http://www.mupnet.com.

Oncogenic Ras Regulates Long Noncoding Rna Orilnc1 In Human Cancer

Data from Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human Cancer

Table S1 from Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer

Table S3 from Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human Cancer

Table S1 from Oncogenic RAS Regulates Long Noncoding RNA <i>orilnc1</i> in Human Cancer

Table S4 from Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human Cancer

Table S2 from Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer

Epigenetic Silencing of a Ca2+-regulated Ras GTPase-activating Protein RASAL Defines a New Mechanism of Ras Activation in Human Cancers

Oncogenesis of RON Receptor Tyrosine Kinase： a Molecular Target for Malignant Epithelial Cancers

A Novel Protein RASON Encoded by a Lncrna Controls Oncogenic RAS Signaling in KRAS Mutant Cancers

A ROR1–HER3–lncRNA Signalling Axis Modulates the Hippo–YAP Pathway to Regulate Bone Metastasis

Long Non-Coding RNA BC087858 Induces Non-T790m Mutation Acquired Resistance to EGFR-TKIs by Activating PI3K/AKT and MEK/ERK Pathways and EMT in Non-Small-cell Lung Cancer

β-Arrestin-1-dependent activation of extracellular signal-regulated kinases in RON receptor-mediated tumorigenic activities in colon cancer cells

ROR1-AS1: A Meaningful Long Noncoding RNA in Oncogenesis

ROR1-AS1 Promotes Tumorigenesis of Colorectal Cancer Via Targeting Wnt/β-catenin.

Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway

RALBP1 Regulates Oral Cancer Cells Via Akt and is a Novel Target of Mir-148A-3p and Mir-148B-3p.

Oncogenic K-Ras suppresses global miRNA function

Long Noncoding RNA ROR1‑AS1 Overexpression Predicts Poor Prognosis and Promotes Metastasis by Activating Wnt/β-catenin/EMT Signaling Cascade in Cervical Cancer

Ribosome profiling analysis identified a KRAS-interacting microprotein that represses oncogenic signaling in hepatocellular carcinoma cells

Long Noncoding RNA ROR1-AS1 Enhances Lung Adenocarcinoma Metastasis and Induces Epithelial-Mesenchymal Transition by Sponging Mir-375.